Inside Amazon’s 'Haven' healthcare joint venture

It has been more than a year since the healthcare joint venture between Amazon, JPMorgan Chase and Berkshire Hathaway was announced. Since then, we haven't heard much — until now. Last week, the venture finally got a name, Haven, and on its new website, the joint venture shared where it will focus within this $8 trillion global industry. And earlier this month, 300 pages of unsealed court documents offered additional clues about Haven’s plans. On this episode of GeekWire's Health Tech podcast, we catch up with health tech entrepreneurs, 98point6 CEO Robbie Cape and Wellpepper CEO Anne Weiler, to get their take on the joint venture's ambitions.

See omnystudio.com/listener for privacy information.